RIFAMATE RIFAMATE (Rifamate 150 mg / 300 mg)
Generic Name: isoniazid/rifampin
Pill imprint RIFAMATE RIFAMATE has been identified as Rifamate 150 mg / 300 mg.
Rifamate is used in the treatment of tuberculosis, active and belongs to the drug class antituberculosis combinations. FDA has not classified the drug for risk during pregnancy. Rifamate 150 mg / 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for RIFAMATE RIFAMATE (Rifamate 150 mg / 300 mg)
- Generic Name:
- 150 mg / 300 mg
- 14.00 mm
- Prescription only
- Drug Class:
- Antituberculosis combinations
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- N - Not a controlled drug
- Aventis Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
FD&C Blue No. 1
FD&C Red No. 40
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|68258-9014||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
Rifamate is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...